Innova Captab Limited Stock: price and insider trades · India
Innova Captab Limited: what insiders have been doing
This page follows insider dealings at Innova Captab Limited as filed with SEBI (PIT + SAST), a company from the Health Care sector. Between 8 November 2025 and 8 November 2026, 5 insiders published 7 filings.
All open-market trades in the period are sales: 3 sales worth €17.9M, by 3 insiders, with no purchase on record. The largest single trade was a sale of €15.4M by Gian Parkash Aggarwal, published on 3 October 2026, equal to 2.9% of the market capitalisation.
Across the 1,986 companies tracked on its exchange, the median is 4 filings; at 7 filings, this issuer sits above that mark. Our records for Innova Captab Limited go back to 2025, with no purchases and 3 sales on the open market in total.
Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Innova Captab Limited Strong Buy (bullish), based on 2 analysts. Average price target: ₹1,116.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 1,550,000 shares@ ₹1,080.002.92% mcap37.6% of flowEquityMarket SaleSEBI:7191ff10560ce8806672dbc4613fe6148749d7f7
- 150,000 shares@ ₹1,080.000.28% mcap5.1% of flowEquityMarket SaleSEBI:10803a90dfc6b0a7237c45b812db62ad307fb1e6
- 100,000 shares@ ₹1,080.000.19% mcap100.0% of flowEquityMarket SaleSEBI:1490ff1c5814d61e750245e3a5bc06610466dcc6
- 350,000 shares@ ₹1,158.200.71% mcap9.1% of flowEquityGiftSEBI:a9950bcd3f0b2bb4af6e24bcd19c145d3d54e69f
- 4,375,000 shares@ ₹691.005.44% mcap100.0% of flowEquity SharesSEBI:2a67b9df99024c39955093cdd5d50075ec214445
- 280,000 shares@ ₹752.459.3% of flowEquity SharesSEBI:766c8b9327eaf9c5759d9addb3b02bb17424ba85
- 250,000 shares@ ₹752.458.3% of flowEquity SharesSEBI:2e315a668847a03a33a98eae7370e6e27bfe29ab
- 1,300,000 shares@ ₹822.0046.8% of flowEquity SharesSEBI:192d55b297231722efc135eeb8c8b558a068270d
- 950,000 shares@ ₹856.0535.6% of flowEquity SharesSEBI:168a1251337885410cf09302237bc32e0e5d952e
9 of 9 declarations
About Innova Captab Limited
Innova Captab Limited is a company operating in the healthcare and pharmaceutical sector. It is listed on the XBOM.
